Cormorant Asset Management, LP Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$4.5T
Holdings
119
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (119 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IWMISHARES TR | 2,000,000 | $441.9B | 9.84% | Put |
| 2 | SPYSPDR S&P 500 ETF TR | 1,000,000 | $396.3B | 8.83% | Put |
| 3 | AVIRATEA PHARMACEUTICALS INC | 6,411,355 | $395.9B | 8.82% | |
| 4 | —TURNING POINT THERAPEUTICS I | 2,750,000 | $260.1B | 5.80% | |
| 5 | DSGNDESIGN THERAPEUTICS INC | 5,114,850 | $146.4B | 3.26% | |
| 6 | XBISPDR SER TR | 1,000,000 | $135.7B | 3.02% | Put |
| 7 | BBIOBRIDGEBIO PHARMA INC | 2,168,909 | $133.6B | 2.98% | |
| 8 | —FORMA THERAPEUTICS HLDGS INC | 4,720,000 | $132.3B | 2.95% | |
| 9 | RVMDREVOLUTION MEDICINES INC | 2,525,000 | $115.8B | 2.58% | |
| 10 | BCABBIOATLA INC | 2,192,060 | $109.9B | 2.45% | |
| 11 | OLMAOLEMA PHARMACEUTICALS INC | 3,195,544 | $105.1B | 2.34% | |
| 12 | CCCCC4 THERAPEUTICS INC | 2,490,065 | $92.1B | 2.05% | |
| 13 | APLSAPELLIS PHARMACEUTICALS INC | 1,866,108 | $80.1B | 1.78% | |
| 14 | OMEROMEROS CORP | 4,300,030 | $76.5B | 1.71% | Call |
| 15 | EWTXEDGEWISE THERAPEUTICS INC | 2,340,914 | $74.3B | 1.66% | |
| 16 | ALXOALX ONCOLOGY HLDGS INC | 881,770 | $65.0B | 1.45% | |
| 17 | —ZYMEWORKS INC | 2,000,000 | $63.2B | 1.41% | |
| 18 | RCKTROCKET PHARMACEUTICALS INC | 1,368,550 | $60.7B | 1.35% | |
| 19 | STOKSTOKE THERAPEUTICS INC | 1,437,807 | $55.8B | 1.24% | |
| 20 | TARSTARSUS PHARMACEUTICALS INC | 1,714,269 | $55.3B | 1.23% | |
| 21 | RNAAVIDITY BIOSCIENCES INC | 2,464,545 | $53.8B | 1.20% | |
| 22 | ACRSACLARIS THERAPEUTICS INC | 2,000,000 | $50.4B | 1.12% | |
| 23 | MRTXEURMIRATI THERAPEUTICS INC | 275,000 | $47.1B | 1.05% | |
| 24 | NVV1NOVAVAX INC | 250,000 | $45.3B | 1.01% | |
| 25 | CCXIEURCHEMOCENTRYX INC | 850,000 | $43.6B | 0.97% | |
| 26 | AXNX*AXONICS MODULATION TECHNOLOG | 693,000 | $41.5B | 0.92% | |
| 27 | DMTKQDERMTECH INC | 800,000 | $40.6B | 0.91% | |
| 28 | RETAEURREATA PHARMACEUTICALS INC | 400,000 | $39.9B | 0.89% | |
| 29 | 1K0IGM BIOSCIENCES INC | 495,769 | $38.0B | 0.85% | |
| 30 | XLRNACCELERON PHARMA INC | 275,000 | $37.3B | 0.83% | |
| 31 | YMABUSDY-MABS THERAPEUTICS INC | 1,230,000 | $37.2B | 0.83% | |
| 32 | —LONGBOARD PHARMACEUTICALS IN | 2,356,000 | $37.2B | 0.83% | |
| 33 | —PROMETHEUS BIOSCIENCES INC | 2,098,024 | $36.6B | 0.82% | |
| 34 | PRAXPRAXIS PRECISION MEDICINES I | 1,074,145 | $35.2B | 0.78% | |
| 35 | VERUEURVERU INC | 3,000,000 | $32.3B | 0.72% | |
| 36 | ALGSALIGOS THERAPEUTICS INC | 1,267,167 | $28.8B | 0.64% | |
| 37 | MASS908 DEVICES INC | 545,322 | $25.9B | 0.58% | |
| 38 | NTLAINTELLIA THERAPEUTICS INC | 300,000 | $24.1B | 0.54% | Put |
| 39 | PLRXPLIANT THERAPEUTICS INC | 611,409 | $24.0B | 0.54% | |
| 40 | 2L9BLUEPRINT MEDICINES CORP | 247,200 | $24.0B | 0.54% | |
| 41 | —APTOSE BIOSCIENCES INC | 4,000,000 | $23.9B | 0.53% | |
| 42 | PHVSPHARVARIS N V | 864,143 | $23.8B | 0.53% | |
| 43 | TWSTTWIST BIOSCIENCE CORP | 185,000 | $22.9B | 0.51% | |
| 44 | SRNESORRENTO THERAPEUTICS INC | 2,750,000 | $22.7B | 0.51% | |
| 45 | MORFMORPHIC HLDG INC | 350,000 | $22.1B | 0.49% | |
| 46 | SPRYSILVERBACK THERAPEUTICS INC | 500,000 | $21.8B | 0.49% | |
| 47 | AKROAKERO THERAPEUTICS INC | 742,549 | $21.5B | 0.48% | |
| 48 | CABACABALETTA BIO INC | 1,904,424 | $21.1B | 0.47% | |
| 49 | AGENEURAGENUS INC | 7,750,000 | $21.1B | 0.47% | |
| 50 | —MYOVANT SCIENCES LTD | 1,000,000 | $20.6B | 0.46% | |
| 51 | ZLABZAI LAB LTD | 150,000 | $20.0B | 0.45% | |
| 52 | —TCR2 THERAPEUTICS INC | 900,000 | $19.9B | 0.44% | |
| 53 | KALVKALVISTA PHARMACEUTICALS INC | 750,000 | $19.3B | 0.43% | |
| 54 | 0KB2HUMANIGEN INC | 1,000,000 | $19.1B | 0.43% | |
| 55 | CNTBCONNECT BIOPHARMA HLDGS LTD | 1,000,000 | $18.5B | 0.41% | |
| 56 | BDQMALBIREO PHARMA INC | 500,000 | $17.6B | 0.39% | |
| 57 | INSPINSPIRE MED SYS INC | 85,000 | $17.6B | 0.39% | |
| 58 | ELDNELEDON PHARMACEUTICALS INC | 1,415,500 | $15.1B | 0.34% | |
| 59 | RPTXREPARE THERAPEUTICS INC | 462,205 | $14.2B | 0.32% | |
| 60 | ANABANAPTYSBIO INC | 650,000 | $14.0B | 0.31% | |
| 61 | BEAMBEAM THERAPEUTICS INC | 171,775 | $13.7B | 0.31% | |
| 62 | —BIOHAVEN PHARMACTL HLDG CO L | 200,000 | $13.7B | 0.30% | |
| 63 | FHTXFOGHORN THERAPEUTICS INC | 1,000,000 | $13.2B | 0.29% | |
| 64 | GLTOUSDGALECTO INC | 2,150,732 | $13.1B | 0.29% | |
| 65 | ASNDASCENDIS PHARMA A/S | 100,000 | $12.9B | 0.29% | |
| 66 | —HARPOON THERAPEUTICS INC | 570,600 | $11.9B | 0.27% | |
| 67 | AXSMAXSOME THERAPEUTICS INC | 200,000 | $11.3B | 0.25% | |
| 68 | TBPHTHERAVANCE BIOPHARMA INC | 550,000 | $11.2B | 0.25% | |
| 69 | 0HJQAVEO PHARMACEUTICALS INC | 1,500,000 | $11.0B | 0.24% | |
| 70 | BNTXBIONTECH SE | 100,000 | $10.9B | 0.24% | |
| 71 | 5E7ITEOS THERAPEUTICS INC | 300,000 | $10.3B | 0.23% | |
| 72 | IM8NINSMED INC | 300,000 | $10.2B | 0.23% | |
| 73 | SWTXSPRINGWORKS THERAPEUTICS INC | 125,000 | $9.2B | 0.20% | |
| 74 | —HEALTH SCIENCES ACQ CORP 2 | 800,000 | $9.0B | 0.20% | |
| 75 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 200,000 | $9.0B | 0.20% | |
| 76 | —BCTG ACQUISITION CORP | 800,000 | $8.9B | 0.20% | |
| 77 | FDMT4D MOLECULAR THERAPEUTICS IN | 200,000 | $8.7B | 0.19% | |
| 78 | QUREUNIQURE NV | 250,000 | $8.4B | 0.19% | |
| 79 | ARGXARGENX SE | 30,000 | $8.3B | 0.18% | |
| 80 | GOSSGOSSAMER BIO INC | 848,382 | $7.8B | 0.17% | |
| 81 | VRDNVIRIDIAN THERAPEUTICS INC | 459,144 | $7.7B | 0.17% | |
| 82 | MRUSMERUS N V | 350,000 | $7.3B | 0.16% | |
| 83 | —MAGENTA THERAPEUTICS INC | 600,000 | $7.1B | 0.16% | |
| 84 | —AKOUOS INC | 499,989 | $6.9B | 0.15% | |
| 85 | —GENETRON HLDGS LTD | 300,000 | $6.4B | 0.14% | |
| 86 | —GEMINI THERAPEUTICS INC | 475,000 | $6.4B | 0.14% | |
| 87 | CGEMCULLINAN ONCOLOGY INC | 150,000 | $6.3B | 0.14% | |
| 88 | —QUOTIENT LTD | 1,500,000 | $5.5B | 0.12% | |
| 89 | TARAPROTARA THERAPEUTICS INC | 350,000 | $5.5B | 0.12% | |
| 90 | IMVTIMMUNOVANT INC | 337,048 | $5.4B | 0.12% | |
| 91 | —BCLS ACQUISITION CORP | 500,000 | $5.3B | 0.12% | |
| 92 | —THERAPEUTICS ACQUISITION COR | 500,000 | $5.3B | 0.12% | |
| 93 | SRPTSAREPTA THERAPEUTICS INC | 70,000 | $5.2B | 0.12% | |
| 94 | —5 01 ACQUISITION CORP | 500,000 | $5.0B | 0.11% | |
| 95 | —VESPER HEALTHCARE ACQSTN COR | 400,000 | $4.6B | 0.10% | |
| 96 | BCELATRECA INC | 293,500 | $4.5B | 0.10% | |
| 97 | MLTXHELIX ACQUISITION CORP | 430,000 | $4.4B | 0.10% | |
| 98 | REPLREPLIMUNE GROUP INC | 125,000 | $3.8B | 0.08% | |
| 99 | TILINSTIL BIO INC | 150,000 | $3.8B | 0.08% | |
| 100 | DTILPRECISION BIOSCIENCES INC | 346,524 | $3.6B | 0.08% |
Page 1 of 2Next